Table 3 Clinical-virological characteristics of patients in different clinical stages
Characteristics | IA (n=121) | IC (n=30) | IT (n=18) | GZ (n=68) |
|---|---|---|---|---|
Age, years | 29 (25, 34) | 32 (27.75, 37) | 25.5 (24, 26) | 31 (26, 39) |
Gender, n (%) | ||||
 Female | 43 (35.5) | 5 (16.7) | 6 (33.3) | 15 (22.1) |
 Male | 78 (64.5.8) | 25 (83.3) | 12 (66.7) | 53 (77.9) |
Body mass index | 20.8 (19.1, 22.6) | 22.2 (21.0, 23.6) | 20.8 (18.7, 22.5) | 21.4 (19.6, 23.4) |
HBV DNA, log 10 IU/mL | 7.7 (5.0, 8.2) | 2.4 (1.7, 3.0) | 8.2 (8.2, 8.2) | 3.2 (1.9, 4.2) |
HBV genotype, n (%) | ||||
 B | 73 (60.3) | 11 (36.7) | 12 (66.7) | 24 (35.3) |
 C | 31 (25.6) | 4 (13.3) | 3 (16.7) | 12 (17.6) |
 Other | 17 (14.1) | 15 (50) | 3 (16.7) | 32 (47.1) |
HBeAg status, n (%) | ||||
 HBeAg positive | 79 (65.3) | 3 (10) | 18 (100) | 8 (11.8) |
 HBeAg negative | 42 (34.7) | 27 (90) | 0 | 59 (86.8) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 1 (1.4) |
 HBsAg, IU/mL | 7192 (1982, 45,333) | 855 (82,1848) | 40,369 (28,156, 52,000) | 1571 (195, 3754) |
Smoker, n (%) | ||||
 No | 113 (93.4) | 23 (76.7) | 16 (88.9) | 60 (88.2) |
 Yes | 8 (6.6) | 7 (23.3) | 2 (11.1) | 8 (11.8) |
Vertical transmission, n (%) | ||||
 No | 91 (75.2) | 24 (80) | 15 (83.3) | 47 (69.1) |
 Yes | 14 (11.6) | 3 (10) | 3 (16.7) | 11 (16.2) |
 Missing | 16 (13.2) | 3 (10) | 0 (0) | 10 (14.7) |
ALT, U/L | 49 (34, 97.75) | 17 (14, 25) | 20 (16.5, 26.5) | 28 (20.5, 33) |
TBIL, mg/dL | 13.7 (10.9, 18.7) | 13.2 (11, 16.8) | 14.8 (10.2,19.1) | 11.4 (9.2, 14.5) |
ALB, g/L | 45.3 (43.35, 47.15) | 47 (46, 49) | 45.5 (44.0, 47.3) | 46.9 (45.3, 48.1) |
FibroScan value, kPa | 5.5 (4.325, 6.475) | 4.7 (4.225, 5.45) | 4.85 (4.3, 5.4) | 4.8 (4.4, 5.4) |